 |
Michael P. Miller
Director
Mr. Miller was appointed as a director of Puma Biotechnology on February 23, 2018. Mr. Miller
most recently served as the Executive Vice President U.S. Commercial of Jazz Pharmaceuticals
plc, a public biopharmaceutical company, from April 2014 until his retirement in September
2020.
From April 2010 to January 2014, Mr. Miller was Senior Vice President and Chief Commercial
Officer of Vivus, Inc., a public biopharmaceutical company. From 2006 to 2010, Mr. Miller
served as Vice President, Sales and Marketing, leading the HER Family Oncology Franchise, of
Genentech, Inc., a biotechnology company and wholly owned subsidiary of Roche Holding Ltd.
From 2003 to 2005, Mr. Miller served as the Senior Vice President, Chief Commercial Officer of
Connetics Corporation, a specialty pharmaceutical company acquired by Stiefel Laboratories,
Inc. Previously, from 1997 to 2001, Mr. Miller served as Vice President of the Urology Business
Unit of ALZA Corporation, a pharmaceutical company acquired by Johnson & Johnson. Prior to
1997, Mr. Miller served 13 years in various sales and marketing positions at Syntex Corporation,
a pharmaceutical company acquired by Roche Holding Ltd. He currently serves as a member of
two non-profit boards, the Leukemia and Lymphoma Society (Silicon Valley Chapter) and the
Zane Beadles Parade Foundation.
Mr. Miller received a B.S. in Business Administration and Finance from the University of San
Francisco and an M.B.A. in Information and Computer Systems from San Francisco State
University. Mr. Miller was selected as a director because of his significant experience and
background in the life sciences industry.
|
Puma Biotechnology, Inc.
10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax
|
